Addressing Involuntary Movements in Tardive Dyskinesia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to determine whether fixed-doses of an investigational drug, SD-809 (deutetrabenazine), will reduce the severity of abnormal involuntary movements of tardive dyskinesia.
Epistemonikos ID: 19ecc0c834693ce8e99009a055cc9ed9e9932b0b
First added on: May 12, 2024